文献速递贫血与红细胞疾病白血病淋巴瘤

基于遗传学的血液系统恶性肿瘤诊断与分类

Diagnosis and classification of hematologic malignancies on the basis of genetics.
PubMed 文献 · Blood · 2017-06-09

本文综述了基因组分析如何影响多种血液系统恶性肿瘤的诊断与临床管理,包括急性白血病、骨髓增生异常综合征、骨髓增殖性肿瘤、非霍奇金淋巴瘤和经典型霍奇金淋巴瘤的遗传学亚类定义。文中列举了RUNX1突变或BCR-ABL1易位定义的新急性髓系白血病亚型、SF3B1突变定义的环形铁粒幼细胞型MDS亚组、BCR-ABL1融合区分慢性髓系白血病与经典MPN,以及B细胞和T细胞淋巴瘤的特征性重排等。

要点

  • RUNX1突变或BCR-ABL1易位定义新的急性髓系白血病亚型。
  • SF3B1突变定义环形铁粒幼细胞型MDS亚组且预后良好。
  • BCR-ABL1融合区分慢性髓系白血病与经典BCR-ABL1阴性MPN。

核心结论

  • 基因组改变的临床评估细化了髓系肿瘤及起源于B细胞、T细胞或自然杀伤细胞的主要淋巴瘤类型的分类。

研究设计与样本

  • 本文为综述,总结遗传学改变在血液系统恶性肿瘤诊断与分类中的作用。

主要发现

  • 急性髓系白血病中RUNX1突变或BCR-ABL1易位定义新亚型,急性淋巴细胞白血病涉及体细胞结构DNA改变。
  • MDS中SF3B1突变定义环形铁粒幼细胞型MDS亚组且预后良好。
  • MPN中BCR-ABL1融合区分慢性髓系白血病与经典BCR-ABL1阴性MPN,后者主要由JAK2、CALR或MPL突变定义。
  • B细胞淋巴瘤中MYC重排(伯基特淋巴瘤)、BCL2重排(滤泡性淋巴瘤)及MYC/BCL2/BCL6重排(高级别B细胞淋巴瘤)对诊断至关重要。
  • T细胞淋巴瘤中间变性大细胞淋巴瘤由ALK、DUSP22/IRF4和TP63的互斥性重排定义。

关键数值与推荐

  • 慢性淋巴细胞白血病中TP53改变和免疫球蛋白重链可变区突变状态对临床管理重要。
  • BRAFV600E突变检测有助于经典型毛细胞白血病和多种组织细胞肿瘤的诊断。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genomic analysis has greatly influenced the diagnosis and clinical management of patients affected by diverse forms of hematologic malignancies. Here, we review how genetic alterations define subclasses of patients with acute leukemias, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), non-Hodgkin lymphomas, and classical Hodgkin lymphoma. These include new subtypes of acute myeloid leukemia defined by mutations in RUNX1 or BCR-ABL1 translocations as well as a constellation of somatic structural DNA alterations in acute lymphoblastic leukemia. Among patients with MDS, detection of mutations in SF3B1 define a subgroup of patients with the ring sideroblast form of MDS and a favorable prognosis. For patients with MPNs, detection of the BCR-ABL1 fusion delineates chronic myeloid leukemia from classic BCR-ABL1- MPNs, which are largely defined by mutations in JAK2, CALR, or MPL In the B-cell lymphomas, detection of characteristic rearrangements involving MYC in Burkitt lymphoma, BCL2 in follicular lymphoma, and MYC/BCL2/BCL6 in high-grade B-cell lymphomas are essential for diagnosis. In T-cell lymphomas, anaplastic large-cell lymphoma is defined by mutually exclusive rearrangements of ALK, DUSP22/IRF4, and TP63 Genetic alterations affecting TP53 and the mutational status of the immunoglobulin heavy-chain variable region are important in clinical management of chronic lymphocytic leukemia. Additionally, detection of BRAFV600E mutations is helpful in the diagnosis of classical hairy cell leukemia and a number of histiocytic neoplasms. Numerous additional examples provided here demonstrate how clinical evaluation of genomic alterations have refined classification of myeloid neoplasms and major forms of lymphomas arising from B, T, or natural killer cells.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Taylor J, Xiao W, Abdel-Wahab O, et al. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017. PMID: 28600336. doi:10.1182/blood-2017-02-734541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。